BOSTON SCIENTIFIC 'BUY' TARGET PRICE REDUCED

Analyst Glenn Novarro of Banc of America Securities maintains his "buy" rating on Boston Scientific, while reducing his estimates for the company. The target price has been reduced from $34 to $30.
Newratings